J BONE ONCOL 潤(rùn)色咨詢(xún)

Journal of Bone Oncology

出版年份:暫無(wú)數(shù)據(jù) 年文章數(shù):398 投稿命中率: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

出版周期:Quarterly 自引率:16.7% 審稿周期: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

前往期刊查詢(xún)

投稿信息

投稿信息
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
暫無(wú)數(shù)據(jù)
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量暫無(wú)數(shù)據(jù) (2022年為100.00%)
自引率
16.7 %
年文章數(shù)
398
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):3484)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):2264次)
作者需知
點(diǎn)擊查看 (點(diǎn)擊次數(shù):1048次)
NCBI查詢(xún)
期刊簡(jiǎn)介
稿件收錄要求

Journal of Bone Oncology?is an?open access journal?and is indexed in Clarivate Analytics'''' Journal Citation Reports/Science Edition as well as PubMedCentral

The?Journal of Bone Oncology?is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to?boneand?cancer.

As the first journal dedicated to?cancer induced bone diseases,?JBO?welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.

The areas covered by the journal include:

  • Bone metastases?(pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)
  • Preclinical models of?metastasis
  • Bone?microenvironment in?cancer?(stem cell, bone cell and cancer interactions)
  • Bone?targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)
  • Cancer?treatment induced?bone?loss (epidemiology, pathophysiology, prevention and management)
  • Bone?imaging (clinical and animal, skeletal interventional radiology)
  • Bone?biomarkers (clinical and translational applications)
  • Radiotherapy and radio-isotopes
  • Skeletal complications
  • Bone?pain (mechanisms and management)
  • Orthopaedic cancer?surgery
  • Primary?bone tumours
  • Clinical?guidelines
  • Multidisciplinary?care

Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour